SCHEMBL1100175

SCHEMBL1100175

COc1cc(CO)c(O)c(-n2nc3ccc(F)cc3n2)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
NPC1 O15118 6/20 0.33
RAB9A P51151 6/20 0.33
MAPT P10636 4/20 0.33
CASP3 P42574 2/20 0.33
SENP8 Q96LD8 2/20 0.33
SENP7 Q9BQF6 2/20 0.33
SENP6 Q9GZR1 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
LMNA P02545 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
FGFR1 P11362 4/20 0.33
FGFR3 P22607 4/20 0.33
AMY1A P0DUB6 2/20 0.32
HTT P42858 1/20 0.32
FGFR2 P21802 3/20 0.32
FGFR4 P22455 3/20 0.32
KDR P35968 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1098570 0.89 ALDH1A1 (0.43) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL1099556 0.86 NPC1 (0.42) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL1098519 0.86 RAB9A (0.46) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL1100125 0.85 NPC1 (0.39) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL1100542 0.85 CACNA1D (0.38) KDM4EMEN1KMT2A
SCHEMBL2580908 0.82 NPC1 (0.35) KDM4ENPC1RAB9AMAPTCASP3
SCHEMBL825195 0.81 MAPT (0.32) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL20943568 0.81 MAPT (0.32) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL20943569 0.81 POLB (0.35) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL29823665 0.81 MAPT (0.32) KDM4EALDH1A1NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346840-B1 UV/VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS NOVARTIS AG (CH) 2013-12-25 EP disclosed
US-8232326-B2 UV/visible light absorbers for ophthalmic lens materials NOVARTIS AG (CH) 2012-07-31 US disclosed
US-20120142877-A1 UV/VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS NOVARTIS AG (CH) 2012-06-07 US disclosed
US-8153703-B2 UV/visible light absorbers for ophthalmic lens materials NOVARTIS AG (CH) 2012-04-10 US disclosed
CN-102203072-A Uv/visible light absorbers for ophthalmic lens materials ALCON INC 2011-09-28 CN disclosed
EP-2346840-A1 UV/VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS Alcon, Inc. (CH) 2011-07-27 EP disclosed
WO-2010053917-A1 UV/VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS ALCON, INC. (CH) 2010-05-14 WO disclosed
US-20100113641-A1 UV/VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS ALCON, INC. (CH) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113641-A1 UV/VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC LENS MATERIALS UACA, CRYZ, CRYAA KDM4E 2433/4885ALDH1A1 617/4885NPC1 3813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.